rediff.com
e.g. Tata motors, Reliance MF, 500570
Mangalam Drugs and Organics Ltd. - Research Center
532637 MANGALAM Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Sep' 24 Jun' 24 Mar' 24 Dec' 23 Sep' 23
Sales 79.94 76.54 102.24 97.34 81.56
Operating profit 8.69 8.19 11.70 6.98 2.19
Interest 3.67 3.75 3.95 3.31 3.24
Gross profit 5.16 4.46 7.80 3.67 -1.02
EPS (Rs) 1.70 1.70 2.24 0.32 -2.25
Quarterly  results in details
Sep' 24 Jun' 24 Mar' 24 Dec' 23 Sep' 23
Other income 0.14 0.02 0.05 - 0.03
Stock adjustment -5.09 -6.20 -0.91 20.63 -16.82
Raw material 43.40 40.53 51.55 46.65 66.90
Power and fuel - - - - -
Employee expenses 10.18 9.57 11.11 8.97 10.11
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 22.76 24.45 28.79 14.11 19.18
Provisions made - - - - -
Depreciation 3.97 3.87 3.86 3.62 3.73
Taxation -1.49 -2.10 0.39 -0.46 -1.19
Net profit / loss 2.69 2.68 3.55 0.50 -3.56
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 15.83 15.83 15.83 15.83 15.83
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 10.87 10.70 11.44 7.17 2.69
GPM (%) 6.45 5.82 7.62 3.77 -1.25
NPM (%) 3.35 3.51 3.47 0.51 -4.36
Close
Add Mangalam Drugs and Organics Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Mangalam Drugs and Organics Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close